Metolate

Role

Indications

Reactions

Secondary

Rheumatoid Arthritis	68.5%
Prophylaxis	9.7%
Osteoporosis	3.8%
Hypertension	1.9%
Gastritis	1.7%
Product Used For Unknown Indication	1.4%
Adverse Reaction	1.3%
Antibiotic Prophylaxis	1.3%
Folate Deficiency	1.3%
Diabetes Mellitus	1.2%
Insomnia	1.2%
Ra	1.2%
Gastrointestinal Disorder	0.9%
Constipation	0.8%
Gastritis Prophylaxis	0.8%
Bronchiectasis	0.7%
Prophylaxis Against Gastrointestinal Ulcer	0.7%
Adverse Event	0.6%
Colitis Ulcerative	0.6%
Drug Use For Unknown Indication	0.6%

Pneumocystis Jiroveci Pneumonia	11.9%
Pyrexia	9.5%
Hepatic Function Abnormal	8.3%
Pseudomonas Infection	7.1%
Clavicle Fracture	6.0%
Organising Pneumonia	6.0%
Hodgkin's Disease	4.8%
Pneumonia	4.8%
Pulmonary Mycosis	4.8%
Tuberculosis Of Genitourinary System	4.8%
Cardio-respiratory Arrest	3.6%
Clear Cell Renal Cell Carcinoma	3.6%
Disseminated Tuberculosis	3.6%
Lymph Node Tuberculosis	3.6%
Pneumonia Bacterial	3.6%
Purulence	3.6%
Renal Failure	3.6%
Herpes Zoster	2.4%
Intentional Drug Misuse	2.4%
Lymphoma	2.4%

Concomitant

Rheumatoid Arthritis	65.3%
Prophylaxis	6.9%
Osteoporosis	4.7%
Gastritis	4.2%
Hypertension	2.7%
Neuropathy Peripheral	1.9%
Antibiotic Prophylaxis	1.8%
Constipation	1.4%
Folate Deficiency	1.2%
Gastritis Prophylaxis	1.2%
Product Used For Unknown Indication	1.2%
Insomnia	1.1%
Urticaria Chronic	1.1%
Asthenopia	0.8%
Bronchiectasis	0.8%
Gastrointestinal Disorder Therapy	0.8%
Prophylaxis Against Gastrointestinal Ulcer	0.8%
Vitamin Supplementation	0.8%
Benign Prostatic Hyperplasia	0.7%
Dyslipidaemia	0.7%

White Blood Cell Count Decreased	10.2%
Interstitial Lung Disease	9.2%
Pyelonephritis Acute	8.2%
Vomiting	7.1%
Gamma-glutamyltransferase Increased	5.1%
Oedema Peripheral	5.1%
Spinal Compression Fracture	5.1%
Tonsillitis	5.1%
Toxic Skin Eruption	5.1%
Eosinophilic Pneumonia	4.1%
Haemoptysis	4.1%
Seborrhoeic Dermatitis	4.1%
Spondylitis	4.1%
Staphylococcal Infection	4.1%
Thoracic Vertebral Fracture	4.1%
Gastroenteritis	3.1%
Glomerulonephritis Rapidly Progressive	3.1%
Intentional Drug Misuse	3.1%
Lower Respiratory Tract Infection	3.1%
Melaena	3.1%